Sharepoint Solutions
PRODUCTS
-
![Pill bottle medical symbol-GettyImages-1141062189]( "Solving Complex Formulation Challenges From Coast To Coast")
We provide science-first solutions for challenging molecules, specializing in particle engineering, bioavailability, and GMP manufacturing across Bend, OR; Clearwater, FL; and Gainesville, GA.
-
![DNA Helix analysis visualization data-GettyImages-2197575178]( "TARGATT™ Large Knock-In Technology")
Co-invented by Applied StemCell’s President and Chief Scientific Officer, Ruby Tsai, Ph.D., and Head of R&D, Alfonso Farruggio, Ph.D., TARGATT™ large knock-in technology enables rapid, efficient, and precise integration of large DNA fragments—up to 20 kb in a single reaction, more in nested reactions—into a specific intergenic locus.
-
![Nucleus - HEKima]( "Adherent HEK Cell SF Media: HEKima™")
Scale up your viral vector or gene therapy manufacturing cost-effectively with HEKima Adherent, a QuickStart Media designed to simplify customization and accelerate development and production.
-
![GettyImages-1253545551-OSD-pill-tablet-oral-solid-dose]( "Oral Solid Dose Manufacturing")
At Alcami, we provide cGMP manufacturing services that scale with your development and approval milestones, ensuring a seamless transition from clinical to commercial supply.
-
![GettyImages- 1346675538 research]( "Early Phase Trials In Australia")
Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.
WHITE PAPERS AND CASE STUDIES
-
![GettyImages-2095562171-data-tech-network]( "GSK And Medable Discuss The Next Phase Of DCTs")
GSK And Medable Discuss The Next Phase Of DCTsGSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.
-
![GettyImages-1146473276-team-collaboration-partnership-discussion]( "Why Early Market Access Planning Is Crucial In CGT Commercial Strategy")
Why Early Market Access Planning Is Crucial In CGT Commercial StrategyBringing cell and gene therapies (CGTs) to market and ensuring patient access is a complex process. Discover how developing a market access strategy and partnering with experts can help.
-
![Cleanroom Scientists Using Tablet GettyImages-1341292153]( "Liposomal And Nanoparticle Technology")
Liposomal And Nanoparticle TechnologySpecializing in oncology, anti-infective, and complex formulations, Pfizer Melbourne provides manufacturing services for sterile dosage forms.
-
![digital transformation-Digitization of Analog Information-GettyImages-867312356]( "Digitalizing Batch Records In Pharmaceutical Production")
Digitalizing Batch Records In Pharmaceutical ProductionPharma manufacturing embraces cutting-edge automation, yet outdated paper-based documentation hinders efficiency and delays batch releases. See how digital solutions can transform compliance.
-
![GettyImages-836663414 medical team meeting]( "Fortrea Optimizes Site Matching On Retina Clinical Trials")
Fortrea Optimizes Site Matching On Retina Clinical TrialsFaced with challenges in engaging clinical trial sites within the retina research landscape, Fortrea sought a partnership that leverages RWD to streamline site feasibility assessments.
-
![GettyImages-1146439597 data, research, tablet]( "The Evolution Of SDV, SDR, And RBQM In Clinical Trial Data Quality")
The Evolution Of SDV, SDR, And RBQM In Clinical Trial Data QualityExplore the inefficiency of complete SDV and how the adoption of technologies like centralized monitoring, remote SDR, and targeted SDV can enhance data integrity and cost-effectiveness.
-
![GettyImages-1256323645 lab, biotech]( "Advancing In Silico Predictions In Early Drug Discovery")
Advancing In Silico Predictions In Early Drug DiscoveryExamine a high-throughput approach that streamlines LogD measurements, offering faster and more accurate insight into compound lipophilicity to support better decision-making in early drug discovery.
-
![GettyImages-1156179364 data rain]( "Pharma R&D Review 2024: Pleasant Weather Ahead")
Pharma R&D Review 2024: Pleasant Weather AheadGain insights from the 2024 pharma landscape, which reports a record-breaking 22,825 pipeline drugs, led by Pfizer's 32 new candidates and a strong focus on oncology and neurological treatments.
-
![Lab of the Future GettyImages-1449925917]( "Accelerating SARS-CoV-2 Immunotherapy Speed To Clinic")
Accelerating SARS-CoV-2 Immunotherapy Speed To ClinicA clinical-stage biotherapeutics company developing a COVID-19 immunotherapy searched for a solution to the difficulties it faced in scaling up its manufacturing operations due to limited resources.
-
![Outsourcing Business Human Resources--GettyImages-1305829382]( "Enabling CDMOs To Focus On Core Priorities")
Enabling CDMOs To Focus On Core PrioritiesExplore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
![GettyImages-1452403953-patient-recruitment-selection]( "Streamline Recruitment With Confidence")
Streamline Recruitment With ConfidenceTransform your clinical trial recruitment with a service that delivers faster, more cost-effective enrollment, particularly for hard-to-reach populations.
-
![American1]( "AMERICAN Ductile Iron Pipe Used In Northwest Missouri's New Regional Water Authority")
AMERICAN Ductile Iron Pipe Used In Northwest Missouri's New Regional Water AuthorityWhat began as a lofty idea will soon become a reality as a new regional water authority is established in Northwest Missouri. The Great Northwest Wholesale Water Commission will supply water to more than 11,000 people in rural areas of Cameron and Maysville, Missouri, with the capability to expand to other communities in the future.
NEWS
-
New Report Introduces First Legal Blueprint For Climate-Resilient Water And Sanitation In The U.S.11/19/2025
A new report released today by the Pacific Institute and the Center for Water Security and Cooperation (CWSC) provides the most comprehensive framework to date for assessing and improving whether laws enable climate-resilient U.S. water and sanitation systems.
-
Diasorin Submits The LIAISON NES Point-Of-Care Molecular Diagnostics System And 4-Plex Respiratory Panel To The FDA For 510(k) Clearance And CLIA Waiver7/2/2025
Diasorin announces the submission of a 510(k) premarket notification and CLIA waiver application to the U.S. Food and Drug Administration (FDA) for its LIAISON NES, a next-generation molecular POC testing platform.
-
Huachen AI Parking Management Technology Holding Co., Ltd. Expands Smart City Ecosystem With Launch Of 4G Smart Energy Management And Green Power Arbitrage Initiative2/2/2026
Huachen AI Parking Management Technology Holding Co., Ltd. (NASDAQ: HCAI, “Huachen” or the “Company”), a China-based smart-parking and equipment-structural-parts provider in China, today announced the strategic expansion of its Smart City ecosystem with the launch of its 4G Smart Energy Management and Green Power Arbitrage Initiative.
-
Energy Department Slashes 47 Burdensome And Costly Regulations, Delivering First Milestone In America's Biggest Deregulatory Effort5/12/2025
The U.S. Department of Energy (DOE) today announced the first step in the Energy Department’s largest deregulatory effort in history, proposing the elimination or reduction of 47 regulations that are driving up costs and lowering quality of life for the American people.
-
CSU And EPA Partner To Expand Water Data Access10/2/2025
The Radical Open Science Syndicate (ROSS) — a watershed data science lab in the Warner College of Natural Resources — partnered with the U.S. Environmental Protection Agency to improve water data access through Tools for Automated Data Analysis, or TADA, a toolkit empowering water resource managers to use the data they collect.